Patricia dos Santos Azeredo

Ms. Patricia dos Santos Azeredo

Biology Institute, UNICAMP, Campinas, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Cells
Verified
Journal Article
Open access
PDF file
Patricia dos Santos AzeredoPatricia dos Santos Azeredo
Patricia dos Santos Azeredo
DFDaping Fan
Daping Fan
EME. Angela Murphy
E. Angela Murphy
Wayne CarverWayne Carver
Wayne Carver
Increased production of extracellular matrix is a necessary response to tissue damage and stress. In a normal healing process, the increase in extracellular matrix is transient. In some instances; however, the increase in extracellular matrix can persist as fibrosis, leading to deleterious alterations in organ structure, biomechanical properties, and function. Indeed, fibrosis is now appreciated to be an important cause of mortality and morbidity. Extensive research has illustrated that fibrosis can be slowed, arrested or even reversed; however, few drugs have been approved specifically for anti-fibrotic treatment. This is in part due to the complex pathways responsible for fibrogenesis and the undesirable side effects of drugs targeting these pathways. Natural products have been utilized for thousands of years as a major component of traditional medicine and currently account for almost one-third of drugs used clinically worldwide. A variety of plant-derived compounds have been demonstrated to have preventative or even reversal effects on fibrosis. This review will discuss the effects and the underlying mechanisms of some of the major plant-derived compounds that have been identified to impact fibrosis.

4 March 2022 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
MMMara Rubia Marques
Mara Rubia Marques
PAPedro Henrique Graciano de Assis
Pedro Henrique Graciano de Assis
Patricia dos Santos AzeredoPatricia dos Santos Azeredo
Patricia dos Santos Azeredo
JFJaqueline Aguiar Fleury
Jaqueline Aguiar Fleury
JCJanaina Ribeiro Costa
Janaina Ribeiro Costa
FSFernanda Cristina Alcântara dos Santos
Fernanda Cristina Alcântara dos Santos

Verified
Journal Article
Open access
PDF file
Patricia dos Santos AzeredoPatricia dos Santos Azeredo
Patricia dos Santos Azeredo
CFCharity Fix
Charity Fix
Laena PernomianLaena Pernomian
Laena Pernomian
CWCamilla Ferreira Wenceslau
Camilla Ferreira Wenceslau
GPGerardo G Piroli
Gerardo G Piroli
Wayne CarverWayne Carver
Wayne Carver
Oxidative stress is a common feature of various pathological conditions, including tissue remodeling and dysfunction. Cardiac fibroblasts, which play a key role in maintaining extracellular matrix homeostasis, are sensitive to oxidative injury. Curcumin and tetrahydrocurcumin are plant-derived polyphenols with antioxidant properties, yet their relative efficacy in preventing oxidative stress–induced dysfunction in cardiac fibroblasts remains unclear. In this study, cardiac fibroblasts were treated with curcumin or tetrahydrocurcumin prior to exposure to tert-butyl hydroperoxide (t-BHP), a widely used inducer of oxidative stress. Cell viability, apoptosis, reactive oxygen species (ROS) production, and Tgfb1 expression were assessed. Both curcuminoids significantly attenuated oxidative stress–induced cell death, decreased cell viability, and reduced Tgfb1 expression. Notably, tetrahydrocurcumin demonstrated superior protective effects across most parameters. These findings suggest that both compounds help mitigate oxidative-stress–induced cellular dysfunction in cardiac fibroblasts and highlight tetrahydrocurcumin as a potentially more effective antioxidant. Further studies are needed to explore their role in the context of tissue remodeling and fibrotic progression.

27 July 2026 in Research Square
Verified
Preprint
Open access
PDF file
Patricia dos Santos AzeredoPatricia dos Santos Azeredo
Patricia dos Santos Azeredo
DMDiogo de Moraes
Diogo de Moraes
LPLaena Pernomian
Laena Pernomian
CVCristina Pontes Vicente
Cristina Pontes Vicente
Epicatechin, a flavonoid commonly found in cocoa and plant-derived products, has been associated with potential cardiovascular benefits. However, its effects on blood pressure remain unclear. This study aimed to evaluate the impact of epicatechin and epicatechin-rich interventions on blood pressure in adults. A systematic review was conducted according to PRISMA guidelines and registered in PROSPERO (CRD420261340640). Interventional studies involving adult participants with normal blood pressure, elevated values, or hypertension were included. Studies evaluating epicatechin supplementation or epicatechin-rich interventions with a comparator group were considered. Following screening, thirteen studies met the eligibility criteria and were included in this review. Overall, most studies did not report significant differences in systolic or diastolic blood pressure between intervention and control groups. A small number of studies reported reductions in SBP and/or DBP, primarily in healthy individuals, with no consistent pattern of effect observed according to dosage, intervention type, or duration. Although some studies reported reductions, particularly in healthy populations, the overall evidence does not support a clear antihypertensive effect of epicatechin. Further well-designed clinical trials in hypertensive populations are needed to better establish epicatechin's efficacy.